Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

Taking weight loss drugs like Wegovy and Zepbound can help people cut back on what they eat and also on what they drink – ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Weight loss drugs like Ozempic have become a popular option for helping people who struggle to lose weight, but they could ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...